Four erroneous beliefs thwarting more trustworthy research. by Yarborough, Mark et al.
UC Davis
UC Davis Previously Published Works
Title
Four erroneous beliefs thwarting more trustworthy research.
Permalink
https://escholarship.org/uc/item/3tn387zk
Journal
eLife, 8
ISSN
2050-084X
Authors
Yarborough, Mark
Nadon, Robert
Karlin, David G
Publication Date
2019-07-29
DOI
10.7554/eLife.45261
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
POINT OF VIEW
Four erroneous beliefs
thwarting more trustworthy
research
Abstract A range of problems currently undermines public trust in biomedical research. We discuss
four erroneous beliefs that may prevent the biomedical research community from recognizing the
need to focus on deserving this trust, and thus which act as powerful barriers to necessary
improvements in the research process.
MARK YARBOROUGH*, ROBERT NADON AND DAVID G KARLIN
Introduction
In 2014, in an essay titled ‘Why scientists should
be held to a higher standard of honesty than the
average person,’ a former editor of the British
Medical Journal argued that science depends
wholly on trust (Smith, 2014). While many in the
biomedical research community may quibble
over the word ‘wholly’ here, few would dispute
his overall point: the public’s confidence is
essential to the future of research. According to
a noted scholar on the subject, the best way to
enjoy trust is to deserve it (Hardin, 2002). One
would hope that the research community is a
deserving case, given the existence of safe-
guards such as professional norms, regulatory
compliance and peer review. Unfortunately,
there is an ever-growing body of evidence that
calls into question the effectiveness of these
measures.
This evidence includes, but is by no means
limited to, findings about underpowered studies
(Ioannidis, 2005), routine overestimations of
efficacy (Sena et al., 2010; Tsilidis et al., 2013),
the failure to take prior research into account
(Robinson and Goodman, 2011; Lund et al.,
2016), a propensity to confuse hypothesis-gen-
erating studies with hypothesis-confirming ones
(Kimmelman et al., 2014), a worrisome waste of
resources (Chalmers and Glasziou, 2009), and
the low uptake of critical reforms meant to
improve research (Enserink, 2017; Peers et al.,
2014). A recent popular book, Rigor Mortis, syn-
thesizes such evidence into a compelling narra-
tive that casts the reputation of research in a
negative light (Harris, 2017).
While all of this evidence is cause for concern,
we are most concerned by the reluctance of the
research community to implement the reforms
that could improve research quality. One can
imagine a continuum of research practices that
impact how scientific understanding advances.
At one end one encounters the unforgivable,
such as data fabrication or falsification. At the
other end one finds the perfect, such as pub-
lished research reports so thorough that findings
can be easily reproduced from them.
The concerns of interest to us in what follows
have little to do with the misconduct found on
the unforgivable end of the continuum. Instead,
they fall all along it and pertain to unsound
research practices (such as non-robust reporting
of methods, flawed study designs, incomplete
reporting of data handling, and deficient statisti-
cal analyses) that nevertheless impede the
advance of science. These are the practices that
reform measures could counter if researchers
were less reluctant to adopt them. In an effort to
account for this reluctance, we review four erro-
neous beliefs that we think contribute to it.
We acknowledge that we lack extensive data
confirming the prevalence and distribution of
these beliefs. Thus, readers can form their own
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opinions about whether the beliefs are as wide-
spread as we fear they are. We have come upon
our concerns as a result of our careers related to
biomedical research, which will be the focus of
our remarks below, though we think the issues
are relevant to life sciences research more
broadly. One of us (MY) has extensively studied
how to promote trustworthiness in biomedical
research, and another (RN) has a long and suc-
cessful career devoted to understanding the role
of sound methodologies in producing it. The
final author (DGK) is a preclinical researcher who
was among those who pioneered early efforts to
learn how researchers and research institutions
can meaningfully connect the research commu-
nity with the publics it seeks to serve. We think
this collective pedigree lends credence to our
analysis and to the strategy for moving forward
that we recommend in the conclusion.
Recognizing the barriers to a
greater focus on deserving trust
It’s about the science, not the scientists
Erroneous belief one is that questioning the
trustworthiness of research simultaneously ques-
tions the integrity of researchers. As a result,
many individuals react counterproductively to
calls to improve trustworthiness. They are akin
to pilots who confuse discussions about improv-
ing the flightworthiness of airplanes with criti-
cism of their aviation skills. Though
understandable, such concerns miss the point
(Yarborough, 2014a). The multitude of meth-
ods, materials, highly sophisticated procedures
and complex analyses intrinsic to biomedical
research all create ways for it to err, making it
exceptionally difficult to detect problems
(Hines et al., 2014). These are the critical mat-
ters that all researchers must learn to direct their
attention to. Yet they cannot do so if construc-
tive criticism about how to improve science is
taken personally.
We need to focus on the health of the
orchard, not just the bad apples in it
Erroneous belief two is that the bulk of problems
in research is due to bad actors. There is no
doubt that misconduct is a substantial problem
(Fang et al., 2012). This should not blind us,
however, to how common study design and
data analysis errors are in biomedical research
(Altman, 1994). Indeed, these errors are likely
to increase due to trends in current scientific
practice, particularly the growing size and inter-
disciplinarity of investigative teams
(Wuchty et al., 2007; He and Zhang, 2009;
Gazni et al., 2012). Because they require divi-
sions of labor and expertise, such collaborations
create fertile ground for producing unreliable
research. Affected publications draw much less
scrutiny than those of authors who engage in
misconduct (Steen et al., 2013), and thus prob-
lems in them are likely to be discovered much
later, if at all. For example, consider that the
number of retracted publications is much less
than 1% of published articles (Grieneisen and
Zhang, 2012), yet publication bias has been
found to affect entire classes of research
(Tsilidis et al., 2013; Macleod et al., 2015).
The prevalence of erroneous research results
and the enduring problems they cause require
proactive efforts to detect and prevent them.
What we find instead is a disproportionate
emphasis on detecting and punishing ‘bad
apples.’ The more we concentrate on this, the
more difficult it becomes to identify strategies
that allow us to focus on what should be seen as
more pressing issues.
Our beliefs about self-correcting science
need self-correcting
Erroneous belief three is that science self-cor-
rects. Assumptions that published studies are
systematically replicated/replicable, or are later
identified if they are not, build resistance against
reforms. In theory, reproducibility injects quality
assurance into the very heart of research. When
one adds other traditional safeguards such as
professional research norms and peer review,
the reliability of research seems well guarded.
However, a growing body of research to
check whether scientific results can be repro-
duced confirms the shortcomings of these safe-
guards (Hudson, 2003; Allchin, 2015;
Banobi et al., 2011; Zimmer, 2011;
Twaij et al., 2014; Drew, 2019). We mention
just two examples of this research here. The
Reproducibility Project: Cancer Biology has been
underway for almost five years and originally
sought to reproduce 50 critical cancer biology
studies (Couzin-Frankel, 2013). The project was
scaled back to 18 studies, due largely to costs,
but also because important details about
research methods were unreported in some of
the studies the effort sought to reproduce. As
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for results, of the first 13 completed replication
studies, only five produced results similar to the
original studies while the other eight produced
either mixed or negative results (Kaiser, 2018).
An effort to replicate the findings of 100
experimental studies in psychology journals pro-
duced a similarly low rate of replication. Only
36% of the original findings were replicated
according to the conventional statistical signifi-
cance standard of p<0.05 for an effect in the
same direction (Open Science Collaboration,
2015).
Such findings serve as a vivid wake-up call
that alerts us to how easily and how often erro-
neous research results make their way into print,
often in leading journals. Once there, they may
linger for years or even decades prior to being
discovered (if they are ever discovered) (Jud-
son, 2004; Bar-Ilan and Halevi, 2017), and may
continue to be cited post-discovery
(Steen, 2011). And when errors get corrected, it
is more often due to happenstance than any
kind of methodical effort (Allchin, 2015). All this
is sobering when we consider that erroneous
findings can result in potentially dangerous clini-
cal trials (Steen, 2011).
Further shaking our confidence in the ability
of science to self-correct is how few opportuni-
ties there actually are to confirm results. Efforts
such as the Reproducibility Project: Cancer Biol-
ogy notwithstanding, most research sponsors
and publishers value, and thus fund and publish,
innovative studies rather than research that tries
to confirm past findings. And even if sponsors
did place higher value on confirmatory studies,
the growing complexity of science can make
confirmation difficult, or even impossible
(Jasny et al., 2011). Besides information about
study methods and materials possibly not being
available, studies may also use novel and/or
highly sensitive/volatile study materials
(Hines et al., 2014), impinge on intellectual
property rights (Williams, 2010; Godfrey and
German, 2008), or deal with proprietary data
sets (Peng, 2011). Thus, even if there was a time
in science when there were chances ‘to get it
right’ or when consensus could emerge, that is
no longer the case (Yarborough, 2014b).
Following the rules does not guarantee we
are getting it right
Erroneous belief four is that compliance with
regulations is capable of solving the problems
that gave rise to the regulations themselves.
Governments, research sponsors and publishers
have gone to great lengths to implement
reforms that one hopes contribute to deserved
trust. But this is true only to a point; one can fol-
low all the rules, extensive though they may be,
and still not get it right (Yarborough et al.,
2009). We offer efforts to combat research mis-
conduct in the United States as evidence.
The United States Congress, following a
series of research scandals, issued a mandate for
corrective action to combat falsification, fabrica-
tion and plagiarism. This eventually led to a pro-
gram that endures to this day (Office of
Research Integrity, 2015), requiring federally
funded institutions to investigate allegations of
research misconduct. The much larger body of
poor-quality science is left completely unad-
dressed by these government rules. Research
shows that about 2% of researchers report
engaging in misconduct while fifteen times as
many (30%) report having engaged in practices
that contribute to irreproducible research
(Fanelli, 2009); other studies report even higher
percentages (John et al., 2012; Agnoli et al.,
2017). Yet, due to the need to follow the rules,
resources go overwhelmingly to investigating
misconduct. Thus, while such rules bestow quite
modest protections to research, they require sig-
nificant time, energy and money
(Michalek et al., 2010), and simultaneously pro-
vide a false sense of security that problems are
being resolved – when in fact they are not
(Yarborough, 2014b).
Suggestions to help build cultures
and climates that assure deserved
trust
If we can find a way to shed these erroneous
beliefs, we could become more proactive in
showing how we deserve the public’s trust. We
would not need to start de novo. There are
already some proven solutions, as well as prom-
ising new recommendations and reforms, that
can make inroads on many of the problems iden-
tified above. We highlight just a few of them
below. Broad implementation of such initiatives
could pay valuable dividends. For instance,
When errors get corrected, it is
more often due to happenstance
than any kind of methodical effort
Yarborough et al. eLife 2019;8:e45261. DOI: https://doi.org/10.7554/eLife.45261 3 of 11
Feature Article Point of View Four erroneous beliefs thwarting more trustworthy research
rather than expend extraordinary resources on
investigations of misconduct after it has caused
damage (Michalek et al., 2010), we might
instead fund empirical studies of both existing
and proposed reforms. In consequence, we
could determine which reforms are most capable
of strengthening the overall health of biomedical
research (Ioannidis, 2014).
We recognize that the solutions that we high-
light below do not do justice to them as a class,
but we do believe they constitute a reasonably
representative group. Nor do we mean to sug-
gest that they are without controversy. The main
point of our essay, however, is not to provide a
thorough review of current and proposed
reforms and their individual merits. To do so
would focus readers’ attention on what changes
need to be made in research; our purpose is to
explore erroneous beliefs that may prevent suffi-
cient focus on why changes are needed in the
first place.
Publishing reforms: underway but they
could bemore ambitious
It is encouraging to see that many journals have
begun to implement important reform meas-
ures. Among the most encouraging is that some
now perform rigorous statistical review of appro-
priate studies, or make such reviews available to
peer reviewers or associate editors who request
them. Some journals have also modified their
instructions to authors in order to improve the
reporting of research results. The improved
instructions bring transparency to research and
aid reproducibility efforts. Recent studies of
these modified instructions show that they
improve published preclinical study reports, sug-
gesting that even modest journal reforms can
work to good effect (The NPQIP Collaborative
group, 2019; Minnerup et al., 2016). It should
be noted, though, that the benefits of such
reforms might be small. A recent study showed
that a checklist designed to improve compliance
with the ARRIVE guidelines had a quite limited
effect (Hair et al., 2018), showing that having
helpful tools is no guarantee that they will be
used. Thus, it remains unclear what the ultimate
impact of such reform measures might be.
With this evidence in mind, it would be nice if
journals were even more ambitious and took on
some more novel recommendations. One exam-
ple is to consider expanding the taxonomy for
correcting and retracting publications so that
authors can avoid the current stigma around cor-
recting the scientific record (Fanelli et al.,
2018). This would make it possible to take up a
2016 recommendation to reward authors for
self-corrections and retractions (Fanelli, 2016). If
authors felt safe bringing honest errors to the
attention of others, it would encourage much-
needed openness about the mistakes that inevi-
tably occur within fields as complex as biomedi-
cal research.
Researcher practices: plentiful
recommendations with too few takers
Publisher reforms can only accomplish so much.
Most of the improvements that are required to
demonstrate how the research community
deserves the public’s trust need to arise from
how research is conducted. A wealth of thought-
ful recommendations are already in place, but
too many are awaiting widespread adoption.
Among the most notable are a set of recommen-
dations for increasing value and reducing waste
in biomedical research that appeared as part of
a series of articles in The Lancet in 2014.
Those recommendations center around sev-
eral needs: to carefully set research priorities;
improve research design, conduct and analysis;
improve research regulation and management;
reduce incomplete or unusable reports of stud-
ies; and make research results more accessible
(Macleod et al., 2014; Chalmers et al., 2014;
Ioannidis et al., 2014; Salman et al., 2014;
Glasziou et al., 2014; Chan et al., 2014). The
series has not gone without notice, with more
than 46,000 downloads of articles in the series
within the first year of publication (Moher et al.,
2016) and over 900 citations (as of early 2019) in
PubMed Central registered articles. Early evi-
dence suggested that the series placed the
issues that it addressed on the radar screens of
research sponsors, regulators and journals. Dis-
appointingly, academic institutions initially did
not seem to pay them much notice
(Moher et al., 2016). This reinforces our concern
If authors felt safe bringing honest
errors to the attention of others, it
would encourage much-needed
openness about the mistakes that
inevitably occur within fields as
complex as biomedical research.
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that we need to identify what it is about the
mindset of so many in the research community
that is currently stifling interest in reform. So
long as this lack of interest persists, there is little
hope that what we consider the highest impact
changes will occur anytime soon. We have two
such changes in mind that researchers them-
selves need to take more of the lead on.
We need to improve research design and
its reporting
Researchers need to pay more attention to
research methodology, given its central role in
establishing the reliability of published research
results. Some journals now encourage this
behavior by, for instance, requiring that authors
complete checklists to indicate whether or not
they have used study design procedures such as
blinding, randomization and statistical power
analysis. Depending on the journal and type of
study, modest to substantial gains in reporting
prevalence of study design details are achieved
when researchers can complete these require-
ments (The NPQIP Collaborative group, 2019;
Hair et al., 2018; Han et al., 2017). Such
improved reporting allows for better assessment
of the published literature. Better still would be
researchers routinely using universally accepted
basic procedures. For example, it is widely
acknowledged that for animal studies, randomly
allocating animals to groups and blinding experi-
menters to group allocations is required for
sound statistical inference (Macleod, 2014).
We need to increase data sharing
Routine sharing of data should be the new
default for researchers, unless there are compel-
ling reasons not to share. Data sharing can,
among other things, promote reproducibility,
improve the accuracy of results, accelerate
research, and promote better risk-benefit analy-
sis in clinical trials (Institute of Medicine, 2013).
Despite the growing consensus about the value
that data sharing brings to research, we must
acknowledge that when and how data sharing
should occur remains controversial. As recently
noted, “[s]ome argue that the researchers who
invested time, dollars, and effort in producing
data should have exclusive rights to analyze the
data and publish their findings. Others point out
that data sharing is difficult to enforce in any
case, leading to an imbalance in who benefits
from the practice – a problem that some
researchers say has yet to be satisfactorily
resolved” (Callier, 2019). Given such issues, it
comes as no surprise that compliance with
journal data sharing policies can be lackluster
(Stodden et al., 2018).
Taking these difficulties into consideration,
realistic suggestions to encourage data sharing
include: 1) that all journals implement a clear
data sharing policy (Nosek et al., 2015) that
allows reasonable flexibility to take into account
cases when data cannot be shared because of
ethical or identity protection concerns, or that
allow ‘embargo’ periods during which data are
not shared (Banks et al., 2019); 2) that journals
systematically require data sharing during the
review process, to help reviewers to evaluate
the results (this would have the additional bene-
fit of meaning that no additional effort is
required afterward to make the data public); 3)
that training courses in Responsible Conduct of
Research (RCR) include methods to de-identify
study participants and aggregate their results (a
major prerequisite to data sharing [Banks et al.,
2019]); and 4) the creation of awards for
researchers who promote data sharing
(Callier, 2019).
Finally, we need to know whether improved
methodology and increased data sharing are
really leading to reproducible research. Unfortu-
nately, we could not locate studies that have
addressed this question, making this an impor-
tant line of future research.
Institution level practices: promising and
proven remedies looking for suitors
When it comes to institutional practices that
could strengthen the trustworthiness of
research, surely the holy grail would be to better
align researcher incentives with good science
(Ware and Munafo`, 2015). This would be a
heavy lift since it would involve changes to how
institutions collectively approach recruitment,
tenure and promotion. Rather than relying upon
current surrogates such as bibliometrics for
assessing faculty productivity and success
(McKiernan, 2019), they would need to use
more direct measures of good science. A work-
shop involving research quality and other
experts was convened in Washington DC in
2017 to explore what such measures might be
and how they might be used. It identified six key
principles that institutions could embrace to
effect such a transition (Moher et al., 2018), but
their effectiveness remains untested as they
have yet to be implemented. It is worth noting,
however, that at least one institution – the Uni-
versity Medical Center Utrecht – has tried to
reengineer how it assesses its research programs
and faculty in order to better align incentives
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with good science. In the words of the cham-
pions of that change initiative, they are learning
how to better “shape the structures that shape
science. . .[to] make sure that [those structures]
do not warp it” (Benedictus et al., 2016).
There are smaller scale reforms that institu-
tions could also embrace to help ensure high
quality standards in research. For example, there
are many innovative practices that institutions
could currently use to prevent problems, but are
not. Perhaps the most obvious one is a research
data audit. Akin to a finance audit, a research
data audit is meant to check that published data
are “quantifiable and verifiable" by examining
“the degree of correspondence of the published
data with the original source data” (Sha-
moo, 2013). First proposed at scientific confer-
ences in the 1970 s, (Shamoo, 2013) and later in
print in Nature in 1987 (Dawson, 1987), such
audits “would typically require the examination
of data in laboratory notebooks and other work
sheets, upon which research publications are
based” (Glick, 1989). Advocates argue that data
audits should be routine in as many settings as
possible. This would provide a double benefit; it
would help to deter fraud on the one hand and
promote quality assurance on the other
(Shamoo, 2013).
The FDA and the United States Office of
Research Integrity currently conduct such audits
‘for cause’ when misconduct or other misbehav-
iors are suspected. The FDA also uses them for
certain new drugs deemed to be potentially
‘high risk.’ Although most current audits typically
review the proper use of specified research pro-
cedures, there is no reason that they could not
also be used to encourage the proper genera-
tion and use of actual data (Shamoo, 2013).
Critical incident reporting (CRI) is another
promising prevention practice. It can be used to
uncover problems, that, if left unchecked, might
prove detrimental to a group’s research or
reports about their research. Open software
exists for implementing such a system. Accessed
anonymously online, the system prompts users
to report in their own terms what happened that
is of concern to them. Experts can then promptly
analyze incidents to see what systems changes
might prevent future recurrences. The first
adopters of such a system report that it “has led
to the emergence of a mature error culture, and
has made the laboratory a safer and more com-
municative environment” (Dirnagl et al., 2016).
The same opportunity pertains to two other
successful problem reduction methods: root
cause analysis (RCA) and failure modes and
effects analysis (FMEA) (Yarborough, 2014a).
RCA examines past near misses and problems in
order to identify their main contributors. FMEA
anticipates ways that future concerns might
occur and prioritizes the severity of negative
consequences if they do occur (for example, in
aviation one might compare increased fuel con-
sumption by a plane versus the catastrophic fail-
ure of a wing). The most critically needed
preventive measures can then be targeted to
avoid severe problems occurring in the first
place.
RCA and FMEA have both been used to
good effect across a wide spectrum of industries
and endeavors, including the pharmaceutical
industry and clinical medicine. Their track record
clearly shows that they can be used to reduce
medication, surgical and anesthesia errors, and
ensure quality in the drug manufacturing pro-
cess. Both these methods lend themselves most
easily to manufacturing and engineering set-
tings, but their successes suggest they also war-
rant testing for use in research. In particular,
they may improve the human factors that can
lead to avoidable problems, especially in team-
based science settings where geographic disper-
sion and distributed expertise are the norm
(Yarborough, 2014a; Dirnagl et al., 2016).
It seems clear that data audits, CRI, RCA, and
FMEA each have tremendous potential for
improving research: potential that, like the
above publishing reforms and researcher practi-
ces, has gone largely untapped to this point. We
worry that the four erroneous beliefs that we
have highlighted are blunting curiosity about the
health of biomedical research, and are thereby
preventing the adoption of a more proactive
stance toward quality concerns. Hence, a critical
next challenge is learning how to erode the
appeal of these beliefs.
One strategy that we think is particularly
worth considering is education. A wider appreci-
ation of evidence that demonstrates the range
and extent of quality concerns in research, com-
bined with evidence about how few of them
stem from research misconduct, should diminish
belief that a few bad apples are our biggest
problems. A placeholder for this education is
already in place. RCR education is now firmly
ensconced in many graduate and postgraduate
life sciences courses and could naturally incorpo-
rate modules that tackle the erroneous beliefs
head on.
We should note, however, that this strategy is
far from perfect, given longstanding concerns
about the effectiveness of RCR curricula
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(Antes et al., 2010; Presidential Commission
for the Study of Bioethical Issues, 2011) and
the fact that sponsors who mandate RCR instruc-
tion, like the National Institutes of Health (NIH)
and the National Science Foundation (NSF) in
the United States, often stipulate content that
needs to be covered by it. The latter challenge
need not be insuperable, though, since both
NIH and NSF also encourage innovation and cus-
tomization of RCR learning activities. Using RCR
education as a vehicle for fostering improved
quality in research may also help to make such
instruction appear more relevant to the careers
of learners.
As an example, RCR sessions could examine
the scientific record on self-correction. The
aforementioned cancer and psychology replica-
tion projects would surely warrant consideration,
but we think that an equally relevant and highly
illustrative case study showing how this might be
done is a recently published study
(Border et al., 2019) about the lasting detrimen-
tal impact of a 1996 study about the SLC6A4
gene on depression research (Lesch et al.,
1996). This publication spurred at least an addi-
tional 450 published ones, consumed millions of
dollars, and controversy about it continues to
this day (Yong, 2019). Such case studies can
drive home multiple lessons because they simul-
taneously show how science cannot be relied
upon to self-correct in a timely or efficient way
and that regulations often fail to touch upon
matters critical to the health of research.
Conclusion
Readers may be tempted to dismiss the forego-
ing analysis of erroneous beliefs as mere per-
sonal observations. They may prefer instead
either hard data about how research measures
up against metrics that contribute to deserving
trust. Or they may wish for yet another round of
study design and data analysis
recommendations capable of solving the broad
range of ills currently diminishing the quality of
research. The recommendations would plot the
path to progress while the data would make our
pace of progress apparent to all.
As we have tried to make clear, there are
plenty of thoughtfully tailored recommendations
that have not yet resulted in the improvements
to research they are surely capable of producing
– simply because there has been too little
uptake of them. Nor, for that matter, is there
any shortage of calls to arms and manifestos,
including those from some of the most eminent
scholars and leaders in biomedical research
(Alberts et al., 2014; Munafo` et al., 2017).
Since these have had such little effect so far,
especially at the institutional level, it is not clear
why we would expect yet more recommenda-
tions to enjoy a better reception. Besides, many
questionable research practices are hidden from
view. For example, inconvenient data points, or
even entire experiments, are at times ignored
(Martinson et al., 2005); data are added to
experiments until desired p-values are obtained
(Simmons et al., 2011); and unreliable methods
are used when randomizing animals in studies
(Institute for Laboratory Animal Research
Roundtable on Science and Welfare in Labora-
tory Animal Use, 2015). Because these behav-
iors are hidden, traditional metrics are unlikely
to capture their extent or their influence on the
trustworthiness of research.
These behaviors notwithstanding, ‘open sci-
ence’ practices would be one way to increase
confidence in research results that could also
provide metrics of trustworthiness. For example,
some questionable research practices, such as
p-hacking (Head et al., 2015), could be
detected more easily by requiring that data and
analysis code be publicly available in all but the
most exceptional circumstances. Indeed, one
group has called for traditional institutional per-
formance metrics such as impact factor and
number of publications to be replaced with
open science metrics (Barnett and Moher,
2019). Although measurable open science
would not eliminate questionable research prac-
tices, it would move biomedical research toward
increased accountability.
Open science practices are still no panacea,
however, for all the quality concerns we have
highlighted here. What is most needed at this
juncture is a collective focus on deserving trust.
Such a focus could make researchers and the
leaders of research institutions more receptive
to reform efforts. The four erroneous beliefs we
There are plenty of thoughtfully
tailored recommendations that have
not yet resulted in the
improvements to research they are
surely capable of producing
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have discussed surely hinder that collective
focus, and thus deter the research community
from adopting reforms that can secure the pub-
lic’s trust – which is vital to biomedical research.
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